Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: NGF6-E test formulation
Total 0 results
Nothing found
Sponsors and Collaborators
Centre Hospitalier du Quebec
Pompeyo Stalin Alarcón Vigil
Worabe Comprehensive Specialiazed Hospital
Maria de las Mercedes Perez Rodriguez
Nelson Mandela Academic Hospital
Shenzhen Core Medical Technology CO.,LTD.
Saw Swee Hock School of Public Health
Pharmacy Board of Sierra Leone, Ministry of Health and Sanitation
MYOR Ltd.
Donald B. Kohn, M.D.
Didem OZKAL EMINOGLU
Roongroj Bhidayasiri
Sociedad Panameña de Hematología
Shaoxing Mashan Street Community Health Service Center
Sub-Investigator: Łucja Bieleninik, PhD
The Institute of Neuropsychiatry and Addictions (INAD), Parc de Salut Mar, Barcelona
Dr. Jochen Brack
Steven B. Kleiboeker
Hospital Governador Celso Ramos
Universidad Mayor de San Simón (UMSS, Bolivia)
View Full List
Medical Conditions
Bladder Cancer Recurrent
Inoperable Stage III Non-small Cell Lung Cancer
Poor Medication Adherence
Endoscopic Surveillance
Pharmacokinetics of Ipragliflozin
0.5-14 Year Old Children With Nephroblastoma
Humerus Fracture Displaced Proximal
Urinary Bladder Neurogenic Dysfunction
Malignant Tumor of Urinary System (Disorder)
Anticoagulant Prophylaxis/Therapy
Atherosclerosis Coronary Artery With Angina Pectoris
Small Intestine Cancer
Root Abscess
Parental
Macrocephaly Autism Syndrome
Bladder Recurrence
Control Nausea and Vomiting
Granulomatous Disease, Chronic
Memory Disorders
Neuroectodermal Tumor
View Full List
Drug Interventions
Biphasic insulin aspart 30
Idelalisib
Letrozole
Bupropion Extended Release Oral Tablet
Sparsentan
Everolimus
Campath 1H
Fibrin Sealant
Clozapine 100 mg
APG2575 800 mg
SAR408701 (Tusamitamab ravtansine)
Elafibranor 80mg
Ceralasertib
Salvinorin A
Cyclosporine A
Varenicline Controlled Release 1.2 mg
Vehicle
The drug "Rutan 0.1".
Rabeprazole, amoxicillin, tetracycline, furazolidone (only for the first 7 days), colloidal bismuth pectin (for the second 7 days)
FTD regimen
View Full List
CROs by country
Contract Research Organizations in Bangladesh
Contract Research Organizations in Benin
Contract Research Organizations in Denmark
Contract Research Organizations in Greece
Contract Research Organizations in Kuwait
Contract Research Organizations in Mexico
Contract Research Organizations in Mongolia
Contract Research Organizations in Morocco
Contract Research Organizations in Mozambique
Contract Research Organizations in Myanmar
Contract Research Organizations in Pakistan
Contract Research Organizations in Türkiye
Contract Research Organizations in Venezuela
CRO list by country
CROs in Congo
SGS
All CROs in Congo
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe